We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRT
2776
DELISTED
MedEquities Realty Trust, Inc.
MRT
$117K ﹤0.01%
+10,563
New +$118K
AGTC
2777
DELISTED
Applied Genetic Technologies Corporation
AGTC
$116K ﹤0.01%
12,395
+943
+8% +$8.49K
XONE
2778
DELISTED
The ExOne Company
XONE
$116K ﹤0.01%
12,391
-3,258
-21% -$37.2K
JAKK icon
2779
Jakks Pacific
JAKK
$301M
$115K ﹤0.01%
2,227
-94
-4% -$6.51K
PFSW
2780
DELISTED
PFSweb, Inc.
PFSW
$115K ﹤0.01%
13,574
+851
+7% +$7K
NIHD
2781
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$114K ﹤0.01%
52,907
-3,214
-6% -$7.54K
VCYT icon
2782
Veracyte
VCYT
$3.7B
$110K ﹤0.01%
14,248
+1,105
+8% +$8.27K
LFVN icon
2783
LifeVantage
LFVN
$81.1M
$109K ﹤0.01%
13,403
-8
-0.1% -$68
RCKT icon
2784
Rocket Pharmaceuticals
RCKT
$340M
$109K ﹤0.01%
4,456
-396
-8% -$11.3K
ECYT
2785
DELISTED
Endocyte, Inc. Common Stock
ECYT
$109K ﹤0.01%
42,706
-1,731
-4% -$4.97K
III icon
2786
Information Services Group
III
$199M
$107K ﹤0.01%
29,434
+8,490
+41% +$32.8K
IMUX icon
2787
Immunic
IMUX
$190M
$107K ﹤0.01%
61
-16
-21% -$35K
TVIA
2788
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$106K ﹤0.01%
92,437
-5,283
-5% -$9.59K
BPTH
2789
DELISTED
Bio-Path Holdings Inc
BPTH
$105K ﹤0.01%
19
-2
-10% -$9.69K
CLD
2790
DELISTED
Cloud Peak Energy Inc
CLD
$105K ﹤0.01%
18,735
+590
+3% +$3.56K
LIND icon
2791
Lindblad Expeditions
LIND
$1.94B
$103K ﹤0.01%
10,946
-1,095
-9% -$9.99K
OSIR
2792
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$103K ﹤0.01%
20,882
+1,313
+7% +$6.72K
WTI icon
2793
W&T Offshore
WTI
$534M
$99K ﹤0.01%
35,847
-7,830
-18% -$14.6K
HLTH
2794
DELISTED
Nobilis Health Corp.
HLTH
$98K ﹤0.01%
46,610
-3,187
-6% -$8.67K
MFIC icon
2795
MidCap Financial Investment
MFIC
$787M
$97K ﹤0.01%
5,529
+20
+0.4% +$358
IBRX icon
2796
ImmunityBio
IBRX
$7.51B
$95K ﹤0.01%
16,602
+737
+5% +$4.92K
XRN
2797
Chiron Real Estate Inc
XRN
$514M
$94K ﹤0.01%
+2,100
New +$91K
MCHX icon
2798
Marchex
MCHX
$76.2M
$93K ﹤0.01%
35,172
-22,381
-39% -$59.2K
RGLS
2799
DELISTED
Regulus Therapeutics
RGLS
$89K ﹤0.01%
330
+26
+9% +$8.45K
NMRX
2800
DELISTED
Numerex Corp
NMRX
$89K ﹤0.01%
+12,016
New +$93.3K

Similar funds

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.